![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC25A6 |
Gene summary for SLC25A6 |
![]() |
Gene information | Species | Human | Gene symbol | SLC25A6 | Gene ID | 293 |
Gene name | solute carrier family 25 member 6 | |
Gene Alias | AAC3 | |
Cytomap | X | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | P12236 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
293 | SLC25A6 | GSM4909280 | Human | Breast | Precancer | 9.92e-04 | -6.90e-01 | 0.0305 |
293 | SLC25A6 | GSM4909282 | Human | Breast | IDC | 9.95e-15 | 2.97e-01 | -0.0288 |
293 | SLC25A6 | GSM4909286 | Human | Breast | IDC | 1.01e-07 | 2.80e-01 | 0.1081 |
293 | SLC25A6 | GSM4909291 | Human | Breast | IDC | 2.78e-15 | 3.41e-01 | 0.1753 |
293 | SLC25A6 | GSM4909292 | Human | Breast | IDC | 3.31e-05 | -8.68e-01 | 0.1236 |
293 | SLC25A6 | GSM4909293 | Human | Breast | IDC | 1.22e-37 | -4.21e-01 | 0.1581 |
293 | SLC25A6 | GSM4909294 | Human | Breast | IDC | 6.39e-10 | -3.36e-01 | 0.2022 |
293 | SLC25A6 | GSM4909295 | Human | Breast | IDC | 1.56e-02 | -3.77e-01 | 0.0898 |
293 | SLC25A6 | GSM4909296 | Human | Breast | IDC | 1.20e-15 | 2.25e-01 | 0.1524 |
293 | SLC25A6 | GSM4909297 | Human | Breast | IDC | 8.98e-32 | -5.45e-01 | 0.1517 |
293 | SLC25A6 | GSM4909298 | Human | Breast | IDC | 8.63e-06 | -8.26e-02 | 0.1551 |
293 | SLC25A6 | GSM4909299 | Human | Breast | IDC | 1.03e-06 | -1.90e-01 | 0.035 |
293 | SLC25A6 | GSM4909301 | Human | Breast | IDC | 7.46e-45 | -7.86e-01 | 0.1577 |
293 | SLC25A6 | GSM4909302 | Human | Breast | IDC | 1.11e-12 | -5.37e-01 | 0.1545 |
293 | SLC25A6 | GSM4909304 | Human | Breast | IDC | 8.19e-17 | -2.52e-01 | 0.1636 |
293 | SLC25A6 | GSM4909305 | Human | Breast | IDC | 9.20e-03 | 1.82e-01 | 0.0436 |
293 | SLC25A6 | GSM4909306 | Human | Breast | IDC | 1.91e-02 | 2.24e-01 | 0.1564 |
293 | SLC25A6 | GSM4909308 | Human | Breast | IDC | 2.28e-10 | -8.27e-03 | 0.158 |
293 | SLC25A6 | GSM4909311 | Human | Breast | IDC | 4.93e-42 | -4.00e-01 | 0.1534 |
293 | SLC25A6 | GSM4909312 | Human | Breast | IDC | 2.63e-02 | -1.66e-02 | 0.1552 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006862 | Oral cavity | EOLP | nucleotide transport | 10/2218 | 37/18723 | 9.12e-03 | 4.15e-02 | 10 |
GO:001593131 | Oral cavity | NEOLP | nucleobase-containing compound transport | 48/2005 | 222/18723 | 1.51e-06 | 3.77e-05 | 48 |
GO:19016791 | Oral cavity | NEOLP | nucleotide transmembrane transport | 7/2005 | 20/18723 | 3.51e-03 | 2.06e-02 | 7 |
GO:001574811 | Oral cavity | NEOLP | organophosphate ester transport | 25/2005 | 140/18723 | 7.16e-03 | 3.63e-02 | 25 |
GO:000683916 | Prostate | BPH | mitochondrial transport | 79/3107 | 254/18723 | 6.77e-09 | 2.38e-07 | 79 |
GO:199054210 | Prostate | BPH | mitochondrial transmembrane transport | 34/3107 | 102/18723 | 2.63e-05 | 3.10e-04 | 34 |
GO:001593110 | Prostate | BPH | nucleobase-containing compound transport | 55/3107 | 222/18723 | 1.12e-03 | 6.97e-03 | 55 |
GO:000683917 | Prostate | Tumor | mitochondrial transport | 84/3246 | 254/18723 | 7.17e-10 | 3.57e-08 | 84 |
GO:199054217 | Prostate | Tumor | mitochondrial transmembrane transport | 36/3246 | 102/18723 | 9.84e-06 | 1.43e-04 | 36 |
GO:001593113 | Prostate | Tumor | nucleobase-containing compound transport | 59/3246 | 222/18723 | 3.49e-04 | 2.75e-03 | 59 |
GO:000683926 | Skin | AK | mitochondrial transport | 43/1910 | 254/18723 | 6.18e-04 | 5.42e-03 | 43 |
GO:001593118 | Skin | AK | nucleobase-containing compound transport | 34/1910 | 222/18723 | 1.05e-02 | 4.98e-02 | 34 |
GO:0006839111 | Skin | SCCIS | mitochondrial transport | 24/919 | 254/18723 | 1.68e-03 | 1.84e-02 | 24 |
GO:000683927 | Skin | cSCC | mitochondrial transport | 124/4864 | 254/18723 | 3.54e-15 | 2.81e-13 | 124 |
GO:001593119 | Skin | cSCC | nucleobase-containing compound transport | 105/4864 | 222/18723 | 5.49e-12 | 2.89e-10 | 105 |
GO:199054224 | Skin | cSCC | mitochondrial transmembrane transport | 43/4864 | 102/18723 | 2.68e-04 | 2.16e-03 | 43 |
GO:00068396 | Stomach | GC | mitochondrial transport | 42/1159 | 254/18723 | 4.95e-09 | 5.72e-07 | 42 |
GO:19905424 | Stomach | GC | mitochondrial transmembrane transport | 20/1159 | 102/18723 | 3.71e-06 | 1.49e-04 | 20 |
GO:000683911 | Stomach | CAG with IM | mitochondrial transport | 42/1050 | 254/18723 | 2.58e-10 | 4.44e-08 | 42 |
GO:199054211 | Stomach | CAG with IM | mitochondrial transmembrane transport | 20/1050 | 102/18723 | 8.13e-07 | 4.05e-05 | 20 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501218 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502016 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501616 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0501016 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520818 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0541518 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
hsa0501714 | Breast | Precancer | Spinocerebellar ataxia | 29/684 | 143/8465 | 2.79e-06 | 3.83e-05 | 2.94e-05 | 29 |
hsa042189 | Breast | Precancer | Cellular senescence | 29/684 | 156/8465 | 1.66e-05 | 1.69e-04 | 1.30e-04 | 29 |
hsa0516618 | Breast | Precancer | Human T-cell leukemia virus 1 infection | 33/684 | 222/8465 | 4.29e-04 | 3.31e-03 | 2.53e-03 | 33 |
hsa0501219 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502017 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501617 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0501017 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520819 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0541519 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
hsa0501715 | Breast | Precancer | Spinocerebellar ataxia | 29/684 | 143/8465 | 2.79e-06 | 3.83e-05 | 2.94e-05 | 29 |
hsa0421814 | Breast | Precancer | Cellular senescence | 29/684 | 156/8465 | 1.66e-05 | 1.69e-04 | 1.30e-04 | 29 |
hsa0516619 | Breast | Precancer | Human T-cell leukemia virus 1 infection | 33/684 | 222/8465 | 4.29e-04 | 3.31e-03 | 2.53e-03 | 33 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC25A6 | SNV | Missense_Mutation | novel | c.213N>T | p.Trp71Cys | p.W71C | P12236 | protein_coding | deleterious(0.02) | probably_damaging(0.967) | TCGA-5L-AAT1-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | letrozol | SD |
SLC25A6 | SNV | Missense_Mutation | novel | c.88N>C | p.Glu30Gln | p.E30Q | P12236 | protein_coding | deleterious(0.02) | possibly_damaging(0.9) | TCGA-BH-A0B6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC25A6 | insertion | Frame_Shift_Ins | novel | c.257_258insATCCTCTCTTCTTATGGGATGTCTTAAT | p.Leu87SerfsTer17 | p.L87Sfs*17 | P12236 | protein_coding | TCGA-A8-A08H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SLC25A6 | SNV | Missense_Mutation | novel | c.273N>G | p.Phe91Leu | p.F91L | P12236 | protein_coding | deleterious(0.03) | possibly_damaging(0.503) | TCGA-EK-A2RJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SLC25A6 | SNV | Missense_Mutation | novel | c.88N>A | p.Glu30Lys | p.E30K | P12236 | protein_coding | tolerated(0.07) | possibly_damaging(0.775) | TCGA-VS-A9V3-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
SLC25A6 | SNV | Missense_Mutation | novel | c.132N>C | p.Gln44His | p.Q44H | P12236 | protein_coding | deleterious(0.03) | benign(0.185) | TCGA-VS-A9V5-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | carboplatin | PD |
SLC25A6 | SNV | Missense_Mutation | c.793N>A | p.Glu265Lys | p.E265K | P12236 | protein_coding | deleterious(0.02) | possibly_damaging(0.677) | TCGA-AD-6963-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SLC25A6 | SNV | Missense_Mutation | novel | c.36C>A | p.Phe12Leu | p.F12L | P12236 | protein_coding | tolerated(0.4) | benign(0.038) | TCGA-G4-6297-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | fluorouracil | PD |
SLC25A6 | SNV | Missense_Mutation | c.365C>T | p.Ala122Val | p.A122V | P12236 | protein_coding | deleterious(0.02) | benign(0.331) | TCGA-AG-A02N-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Chemotherapy | folinic | CR | |
SLC25A6 | SNV | Missense_Mutation | c.55G>C | p.Ala19Pro | p.A19P | P12236 | protein_coding | deleterious(0.02) | possibly_damaging(0.861) | TCGA-AH-6903-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fu | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
293 | SLC25A6 | TRANSPORTER, DRUGGABLE GENOME | CLODRONATE | CLODRONIC ACID |
Page: 1 |